on-Invasive Physical Plasma for Preventing Radiation Dermatitis in Breast Cancer: A Randomised Double-Blind Placebo-Controlled Trial - NIPP-RD III

Klinik für Strahlentherapie und Radioonkologie0 个研究点目标入组 140 人开始时间: 2024年1月9日最近更新: 2024年8月19日

适应症

试验速览

暂无简介。

•subjects will only be included in the study if they meet all of the following criteria:
•- age = 18 years (no upper limit)
•- breast-conserving surgery for breast cancer or carcinoma in situ (C50.9)
•- whole-breast irradiation
•- moderately hypofractionated radiation regimen, with or without a boost to the tumour bed (simultaneous-integrated or sequential)
•- oral and written informed consent

•subjects will not be included in the study if any of the following criteria apply:
•- synchronous metastatic disease
•- mastectomy
•- reconstruction with breast implant
•- impaired surgical wound healing at the time of radiation treatment initiation
•- alternative fractionation regimens
•- history of ipsilateral breast irradiation
•- any pre-existing dermatological disorder
•- active dermatitis
•- current treatment with topical or oral corticosteroids
•- patient refusal to participate
•- subjects without legal capacity to understand the nature, scope, significance, or consequences of a clinical trial

发起方

Klinik für Strahlentherapie und Radioonkologie